Oct 14, 2026 · 44 min

AI infrastructure trade collides with debt, rates and weaker risk appetite

AI Trade Faces a Reality Check 10/14/26

The episode tests whether AI spending can support its financing burden as markets rotate defensively and household participation in equities declines.

3 key takeaways

1AI infrastructure companies face tougher scrutiny as debt, GPU economics and customer financing challenge the boom’s durability.
2Hot inflation complicates Federal Reserve policy while investors find selective value in bonds and defensive healthcare stocks.
3A weaker IPO market, declining household participation and concentrated AI exposure point to a more selective investment landscape.

Don't miss

Eli Horton broadens the AI infrastructure debate into a thesis on electrification, energy security and decarbonization that could remain relevant if AI spending slows.

The brief

A technology-led sell-off exposes a broader retreat from risk, with investors questioning AI spending, rising yields and debt while rotating toward healthcare and other defensive areas.

Jackson Ader explains why Oracle increasingly trades like a high-duration neocloud, where cloud growth, GPU pricing, debt and capital needs make financing as important as software demand.

Jeff Sherman weighs a hot CPI report against Federal Reserve policy and bond-market value, while Jeffrey Perlman describes an IPO market offering private equity fewer attractive exits.

Healthcare attracts flows as technology weakens, but the sharper debate comes from Eli Horton: electrification, energy security and decarbonization may outlast a slowdown in AI spending.

The episode closes on a less visible risk: household stock ownership has declined since the pandemic, especially among younger and lower-wealth investors, widening the market’s participation gap.

What was said on this episode

14 statements · 8 positive · 6 negative

Jackson Aderon Oracle CorporationNegative4:24
Oracle now trades like a higher-duration neocloud and is more rate-sensitive than in recent years.
“Oracle trades like more of a neocloud, and it trades with higher duration and higher sensitivity to rates than it has in a number of years.”
Listen at 4:24
Jackson Aderon Oracle Cloud InfrastructurePositive4:59
OCI will comprise about half of Oracle revenue by fiscal 2027.
“We predict that by the end of their fiscal 2027, it's going to be about half of the company's revenue.”
Listen at 4:59
Jackson Aderon Oracle CorporationNegative5:20
Oracle is expected to remain free-cash-flow negative for many years.
“we're talking about going negative free cash flow for many years.”
Listen at 5:20
Jackson Aderon Oracle CorporationPositive7:14
Oracle below $150 offers a steep discount to either OCI or traditional software.
“if the stock price is below $150, we feel like you're getting either the OCI business or their traditional software, their application and database business for a steep discount.”
Listen at 7:14
Jackson Aderon Neocloud providersNegative9:14
Reduced customer prepayments would hurt both fringe and core neocloud providers.
“if we see a continued deterioration in large customers being willing to or being forced to prepay large portions of their contracts then yeah that is going to hurt the fringes certainly of the neocloud trade but also the core of the neocloud trade.”
Listen at 9:14
Jackson Aderon Highly indebted neocloud companiesNegative9:34
The most indebted neocloud companies have the worst stock performance.
“the companies that are taking on the most debt in the neocloud trade are seeing the worst performance in their stock price.”
Listen at 9:34
Jeff Shermanon Fed funds rateNegative13:13
The Fed may raise rates another 50 basis points cumulatively by December or late January.
“Maybe it's December. Maybe it's by the late January meeting where they get to that level of raising another 50 basis points cumulatively.”
Listen at 13:13
Jeff Shermanon Federal ReservePositive13:21
The Federal Reserve should reverse risk-management cuts to restore credibility.
“the Fed needs to do so to establish that credibility.”
Listen at 13:21
Jeff Shermanon Shorter-duration creditPositive14:26
DoubleLine favors analyzable, shorter-duration credit over speculative long-duration bonds.
“We like to keep it simple here. We're looking at very shorter duration credit”
Listen at 14:26
Jeff Shermanon Five-to-seven-year Treasury curvePositive14:55
Investors should favor the five-to-seven-year Treasury curve segment for value.
“our recommendation is to be in that five to seven year part of the curve because it offers value.”
Listen at 14:55
Jeff Shermanon Long-duration bondsNegative15:13
DoubleLine continues avoiding long-duration bonds.
“So we're still avoiding the long end.”
Listen at 15:13
Jared Holzon Eli Lilly and CompanyPositive26:51
Eli Lilly appears best positioned among major pharmaceutical companies over five years.
“I think most around the street think that Eli Lilly is in the best shape over the next five years, just given what they've been able to accomplish and the pipeline.”
Listen at 26:51
Jared Holzon Johnson & Johnson pharmaceutical businessPositive26:59
Johnson & Johnson’s pharmaceutical business is among the best positioned.
“J&J, even though the stock was down a lot yesterday because of issues they're having in medical devices, that pharma business within J&J looks to be one of the best.”
Listen at 26:59
Jared Holzon AbbVie and BiogenPositive27:07
AbbVie and possibly Biogen rank behind the strongest pharmaceutical opportunities.
“And then I would probably say AbbVie and maybe Biogen after that.”
Listen at 27:07

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.